Liu Jining, Li Cheng, Ke Shao, Satyanarayanajois Seetharama D
Department of Pharmacy, National University of Singapore, 117543, Singapore.
J Med Chem. 2007 Aug 23;50(17):4038-47. doi: 10.1021/jm0700868. Epub 2007 Jul 21.
Modulation or inhibition of interaction of cluster of differentiation (CD) adhesion molecules CD2-CD58 has been shown to be therapeutically useful. The analysis of the crystal structure of CD2 complexed with CD58 was carried out to define the epitopes that are important for the interaction of the two proteins. The crystal structure of CD2 indicated that the interaction surface of CD2 with CD58 has two beta-strand structures (F and C strands) with charged residues. On the basis of the crystal structure of the complex CD2-CD58, we have designed beta-hairpin peptides from the beta-strand region of CD2 by conjugating the discontinuous sequences in the protein. The peptides were modeled by molecular dynamics simulation, and their inhibitory activities were evaluated in vitro using two heterotypic cell adhesion assays, E-rosetting and lymphocyte-epithelial cell adhesion assays. Results indicated that 12- and 14-residue conjugate cyclic peptides cKS12 and cDD14 exhibited 60% and 50% inhibition activity, respectively, at 90 microM.
已证明调节或抑制分化簇(CD)粘附分子CD2 - CD58的相互作用具有治疗作用。对与CD58复合的CD2晶体结构进行分析,以确定对这两种蛋白质相互作用至关重要的表位。CD2的晶体结构表明,CD2与CD58的相互作用表面有两个带有带电残基的β链结构(F链和C链)。基于CD2 - CD58复合物的晶体结构,我们通过连接蛋白质中不连续的序列,从CD2的β链区域设计了β发夹肽。通过分子动力学模拟对这些肽进行建模,并使用两种异型细胞粘附试验(E花环试验和淋巴细胞 - 上皮细胞粘附试验)在体外评估它们的抑制活性。结果表明,12个残基和14个残基的共轭环肽cKS12和cDD14在90微摩尔浓度下分别表现出60%和50%的抑制活性。